Logo image of H6D0.DE

HALEON PLC (H6D0.DE) Stock Fundamental Analysis

Europe - FRA:H6D0 - GB00BMX86B70 - Common Stock

4.039 EUR
+0.06 (+1.51%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to H6D0. H6D0 was compared to 53 industry peers in the Pharmaceuticals industry. H6D0 has a medium profitability rating, but doesn't score so well on its financial health evaluation. H6D0 is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year H6D0 was profitable.
In the past year H6D0 had a positive cash flow from operations.
H6D0 had positive earnings in each of the past 5 years.
Each year in the past 5 years H6D0 had a positive operating cash flow.
H6D0.DE Yearly Net Income VS EBIT VS OCF VS FCFH6D0.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

1.2 Ratios

H6D0 has a Return On Assets (4.20%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of 8.92%, H6D0 is in line with its industry, outperforming 43.40% of the companies in the same industry.
H6D0 has a Return On Invested Capital (6.11%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for H6D0 is significantly below the industry average of 15.19%.
Industry RankSector Rank
ROA 4.2%
ROE 8.92%
ROIC 6.11%
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
H6D0.DE Yearly ROA, ROE, ROICH6D0.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

H6D0's Profit Margin of 12.84% is in line compared to the rest of the industry. H6D0 outperforms 54.72% of its industry peers.
In the last couple of years the Profit Margin of H6D0 has grown nicely.
H6D0's Operating Margin of 21.31% is in line compared to the rest of the industry. H6D0 outperforms 50.94% of its industry peers.
In the last couple of years the Operating Margin of H6D0 has grown nicely.
The Gross Margin of H6D0 (60.75%) is worse than 64.15% of its industry peers.
In the last couple of years the Gross Margin of H6D0 has remained more or less at the same level.
Industry RankSector Rank
OM 21.31%
PM (TTM) 12.84%
GM 60.75%
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
H6D0.DE Yearly Profit, Operating, Gross MarginsH6D0.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), H6D0 is destroying value.
H6D0 has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, H6D0 has less shares outstanding
The debt/assets ratio for H6D0 is higher compared to a year ago.
H6D0.DE Yearly Shares OutstandingH6D0.DE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B
H6D0.DE Yearly Total Debt VS Total AssetsH6D0.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

H6D0 has an Altman-Z score of 1.73. This is a bad value and indicates that H6D0 is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.73, H6D0 is not doing good in the industry: 67.92% of the companies in the same industry are doing better.
The Debt to FCF ratio of H6D0 is 5.11, which is a neutral value as it means it would take H6D0, 5.11 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 5.11, H6D0 perfoms like the industry average, outperforming 45.28% of the companies in the same industry.
H6D0 has a Debt/Equity ratio of 0.53. This is a neutral value indicating H6D0 is somewhat dependend on debt financing.
H6D0 has a better Debt to Equity ratio (0.53) than 60.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 5.11
Altman-Z 1.73
ROIC/WACC0.78
WACC7.8%
H6D0.DE Yearly LT Debt VS Equity VS FCFH6D0.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.3 Liquidity

A Current Ratio of 0.98 indicates that H6D0 may have some problems paying its short term obligations.
H6D0 has a worse Current ratio (0.98) than 73.58% of its industry peers.
A Quick Ratio of 0.78 indicates that H6D0 may have some problems paying its short term obligations.
H6D0 has a Quick ratio of 0.78. This is in the lower half of the industry: H6D0 underperforms 64.15% of its industry peers.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.78
H6D0.DE Yearly Current Assets VS Current LiabilitesH6D0.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.59% over the past year.
H6D0 shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.56% yearly.
The Revenue has decreased by -0.61% in the past year.
The Revenue has been growing slightly by 5.78% on average over the past years.
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%N/A
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-5.33%

3.2 Future

H6D0 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.41% yearly.
Based on estimates for the next years, H6D0 will show a small growth in Revenue. The Revenue will grow by 3.34% on average per year.
EPS Next Y5.23%
EPS Next 2Y7.25%
EPS Next 3Y8.26%
EPS Next 5Y8.41%
Revenue Next Year-1.7%
Revenue Next 2Y1.17%
Revenue Next 3Y2.29%
Revenue Next 5Y3.34%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
H6D0.DE Yearly Revenue VS EstimatesH6D0.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B
H6D0.DE Yearly EPS VS EstimatesH6D0.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.1 0.2 0.3

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 19.23, H6D0 is valued on the expensive side.
H6D0's Price/Earnings is on the same level as the industry average.
H6D0's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.42.
A Price/Forward Earnings ratio of 17.06 indicates a rather expensive valuation of H6D0.
H6D0's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of H6D0 to the average of the S&P500 Index (22.94), we can say H6D0 is valued slightly cheaper.
Industry RankSector Rank
PE 19.23
Fwd PE 17.06
H6D0.DE Price Earnings VS Forward Price EarningsH6D0.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of H6D0 indicates a somewhat cheap valuation: H6D0 is cheaper than 75.47% of the companies listed in the same industry.
90.57% of the companies in the same industry are more expensive than H6D0, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.89
EV/EBITDA 8.65
H6D0.DE Per share dataH6D0.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)3.68
PEG (5Y)1.1
EPS Next 2Y7.25%
EPS Next 3Y8.26%

3

5. Dividend

5.1 Amount

H6D0 has a Yearly Dividend Yield of 1.97%.
Compared to an average industry Dividend Yield of 3.00, H6D0 has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, H6D0 has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.97%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
H6D0.DE Yearly Dividends per shareH6D0.DE Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.02 0.04 0.06

5.3 Sustainability

39.53% of the earnings are spent on dividend by H6D0. This is a low number and sustainable payout ratio.
DP39.53%
EPS Next 2Y7.25%
EPS Next 3Y8.26%
H6D0.DE Yearly Income VS Free CF VS DividendH6D0.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
H6D0.DE Dividend Payout.H6D0.DE Dividend Payout, showing the Payout Ratio.H6D0.DE Dividend Payout.PayoutRetained Earnings

HALEON PLC

FRA:H6D0 (10/17/2025, 7:00:00 PM)

4.039

+0.06 (+1.51%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)07-31 2025-07-31
Earnings (Next)10-30 2025-10-30
Inst Owners56.78%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap17.99B
Analysts78.46
Price Target4.94 (22.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.97%
Yearly Dividend0.07
Dividend Growth(5Y)N/A
DP39.53%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.58%
Min EPS beat(2)-1.92%
Max EPS beat(2)7.08%
EPS beat(4)3
Avg EPS beat(4)3.76%
Min EPS beat(4)-1.92%
Max EPS beat(4)7.54%
EPS beat(8)4
Avg EPS beat(8)-10.37%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.51%
Min Revenue beat(2)-5.38%
Max Revenue beat(2)-1.64%
Revenue beat(4)0
Avg Revenue beat(4)-3.11%
Min Revenue beat(4)-5.38%
Max Revenue beat(4)-1.64%
Revenue beat(8)1
Avg Revenue beat(8)-2.55%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.74%
PT rev (3m)-5.35%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.51%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.72%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)-2.42%
Valuation
Industry RankSector Rank
PE 19.23
Fwd PE 17.06
P/S 1.39
P/FCF 7.89
P/OCF 6.8
P/B 0.97
P/tB N/A
EV/EBITDA 8.65
EPS(TTM)0.21
EY5.2%
EPS(NY)0.24
Fwd EY5.86%
FCF(TTM)0.51
FCFY12.68%
OCF(TTM)0.59
OCFY14.71%
SpS2.9
BVpS4.18
TBVpS-2.59
PEG (NY)3.68
PEG (5Y)1.1
Profitability
Industry RankSector Rank
ROA 4.2%
ROE 8.92%
ROCE 8.4%
ROIC 6.11%
ROICexc 6.63%
ROICexgc 4145.85%
OM 21.31%
PM (TTM) 12.84%
GM 60.75%
FCFM 17.65%
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
ROICexc(3y)6.57%
ROICexc(5y)6.04%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.5%
ROCE(5y)8.01%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y12.56%
ROICexc growth 5Y14.99%
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
F-Score6
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 5.11
Debt/EBITDA 3.18
Cap/Depr 98.15%
Cap/Sales 2.83%
Interest Coverage 6.65
Cash Conversion 84.66%
Profit Quality 137.52%
Current Ratio 0.98
Quick Ratio 0.78
Altman-Z 1.73
F-Score6
WACC7.8%
ROIC/WACC0.78
Cap/Depr(3y)107.06%
Cap/Depr(5y)107.33%
Cap/Sales(3y)2.94%
Cap/Sales(5y)3.03%
Profit Quality(3y)156.45%
Profit Quality(5y)128.12%
High Growth Momentum
Growth
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%N/A
EPS Next Y5.23%
EPS Next 2Y7.25%
EPS Next 3Y8.26%
EPS Next 5Y8.41%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-5.33%
Revenue Next Year-1.7%
Revenue Next 2Y1.17%
Revenue Next 3Y2.29%
Revenue Next 5Y3.34%
EBIT growth 1Y4.68%
EBIT growth 3Y5.1%
EBIT growth 5Y9.75%
EBIT Next Year11.73%
EBIT Next 3Y8.25%
EBIT Next 5Y7.5%
FCF growth 1Y12.42%
FCF growth 3Y23.3%
FCF growth 5Y29.57%
OCF growth 1Y9.57%
OCF growth 3Y19.28%
OCF growth 5Y23.96%